Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.44585 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.42372 | 18 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42448 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.38349 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39032 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.47295 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.62449 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43108 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.39209 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.4126 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.41025 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.40131 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.41816 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.41307 | 17 |